Editas Medicine (EDIT) Net Income Growth (1y) (2016 - 2025)
Editas Medicine (EDIT) Net Income Growth (1y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - | -0.46% |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn | 17,802.13% |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn | 59.59% |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn | -10.08% |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn | 63.48% |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - | - |
| 10 | Editas Medicine | 244.46 Mn | 97.82 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 51.28% |
| Jun 30, 2025 | 23.14% |
| Mar 31, 2025 | -19.83% |
| Dec 31, 2024 | -184.76% |
| Sep 30, 2024 | 53.22% |
| Jun 30, 2024 | 86.65% |
| Mar 31, 2024 | 76.83% |
| Dec 31, 2023 | 64.70% |
| Sep 30, 2023 | 91.65% |
| Jun 30, 2023 | 54.36% |
| Mar 31, 2023 | 92.91% |
| Dec 31, 2022 | -71.62% |
| Sep 30, 2022 | -2,255.70% |
| Jun 30, 2022 | -749.27% |
| Mar 31, 2022 | -3,901.13% |
| Dec 31, 2021 | 50.16% |
| Sep 30, 2021 | -1,924.60% |
| Jun 30, 2021 | -169.74% |
| Mar 31, 2021 | -102.39% |
| Dec 31, 2020 | -72.82% |